WeVote

Bill

Bill

HB 1117

In vitro fertilization; legal protections; health care providers; practice of medicine; child or children; human embryos; patient's property; effective date.

2026 Regular Session

Oklahoma bill clarifies IVF provider protections and establishes legal status of human embryos in fertility treatment, affecting access and liability in fertility care.

Referred to Public Health
0
WeVote Research Nonpartisan
Bill Summary · HB 1117

Legislative bill overview

HB 1117 appears to address legal frameworks surrounding in vitro fertilization (IVF) practices in Oklahoma, specifically establishing protections for healthcare providers and defining the legal status of human embryos. The bill likely clarifies medical practice standards, liability protections, and property rights related to embryos used in fertility treatment.

Why is this important

IVF is a significant medical procedure affecting thousands of Oklahoma families annually. Clarifying legal protections for providers and the status of embryos directly impacts access to fertility services, healthcare provider participation, treatment costs, and what happens to stored embryos—issues that have become increasingly contentious nationwide following recent legal developments around embryo status.

Potential points of contention

  • Embryo legal status: Defining embryos as property versus persons has profound implications for storage, donation, and destruction of unused embryos, and may conflict with religious or moral beliefs
  • Provider liability: Protections for healthcare providers could limit patient recourse for adverse outcomes or disputes over embryo disposition
  • Access and equity: Legal frameworks may affect which fertility treatments are available, who can access them, and insurance coverage—potentially creating disparities based on income or location

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.